Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate β-catenin pathway

American Journal of Pathology

Volumn 171, Issue 6, 2007, Pages 1978-1988

  Liu, Yu Ting ^a   Shang, Donghao ^a   Akatsuka, Shinya ^a   Ohara, Hiroki ^a   Dutta, Khokon Kumar ^a   Mizushima, Katsura ^b   Naito, Yuji ^b   Yoshikawa, Toshikazu ^b   Izumiya, Masashi ^c   Abe, Kouichiro ^c   Nakagama, Hitoshi ^c   Noguchi, Noriko ^d   Toyokuni, Shinya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d DOSHISHA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; HERMES ANTIGEN; MESSENGER RNA; MYC PROTEIN; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; PTPRZ1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN FRCC 001; CELL STRAIN FRCC 562; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; KIDNEY; KIDNEY CARCINOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; UNINDEXED SEQUENCE; WISTAR RAT;

EID: 38349041715     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070741     Document Type: Article

References (52)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. New York, Oxford University Press, 2007
2. Iuchi K, Ichimiya A, Akashi A, Mizuta T, Lee Y, Tada H, Mori T, Sawamura K, Lee Y, Furuse K, Yamamoto S, Aozasa K: Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 1987, 60:1771-1775
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper R: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789
4. Eaden J, Abrams K, Mayberry J: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535
5. Toyokuni S: Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996, 20:553-566
6. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Lindgren S, Loof L, Stal P, Wallerstedt S, Aimer S, Sandberg-Gertzen H, Askling J: Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003, 125:1733-1741
7. Hodgson J, Darnton A: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000, 44:565-601
8. Nishigori C, Hattori Y, Toyokuni S: Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004, 6:561-570
9. Preston D, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsui T, Nonaka H, Thompson DE, Soda M, Mabuchi K: Cancer incidence in atomic bomb survivors: Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994, 137:S68-S97
10. Toyokuni S, Okamoto K, Yodoi J, Hiai H: Persistent oxidative stress in cancer. FEBS Lett 1995, 358:1-3
11. Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O: Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987, 47:1867-1869
12. Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O: Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986, 76:107-113
13. Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S: Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995, 86:1150-1158
14. Toyokuni S, Mori T, Dizdaroglu M: DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994, 57:123-128
15. Akatsuka S, Aung TT, Dutta KK, Jiang L, Lee WH, Liu YT, Onuki J, Shirase T, Yamasaki K, Ochi H, Naito Y, Yoshikawa T, Kasai H, Tominaga Y, Sakumi K, Nakabeppu Y, Kawai Y, Uchida K, Yamasaki A, Tsuruyama T, Yamada Y, Toyokuni S: Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol 2006, 169:1328-1342
16. Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER: Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994, 91:2616-2620
17. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997, 22:1019-1027
18. Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H: Vitamin E inhibits apoptosis: DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997, 57:2410-2414
19. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999, 18:3793-3797
20. INK4A tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 2002, 160:419-424
21. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S: Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 2004, 23:3980-3989
22. Dutta KK, Nishinaka Y, Masutani H, Akatsuka S, Aung TT, Shirase T, Lee W-H, Hiai H, Yodoi J, Toyokuni S: Two distinct mechanisms for loss of thioredoxin-biding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest 2005, 85:798-807
23. Lee W, Akatsuka S, Shirase T, Kumar Dutta K, Jiang L, Liu Y, Onuki J, Yamada Y, Okawa K, Wada Y, Watanabe A, Kohro T, Noguchi N, Toyokuni S: α-Tocopherol induces calnexin in renal tubular cells: another protective mechanism against free radical-induced cellular damage. Arch Biochem Biophys 2006, 453:168-178
24. Nishiwaki T, Maeda N, Noda M: Characterization and developmental regulation of proteoglycan-type protein tyrosine phosphatase zeta/ RPTPbeta isoforms. J Biochem (Tokyo) 1998, 123:458-467
25. Yamamoto-Fukuda T, Aoki D, Hishikawa Y, Kobayashi T, Takahashi H, Koji T: Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma. Lab Invest 2003, 83:123-136
26. Hattori Y, Nishigori C, Tanaka T, Uchida K, Nikaido O, Osawa T, Hiai H, Imamura S, Toyokuni S: 8-Hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic UVB exposure. J Invest Dermatol 1996, 107:733-737
27. Goldman L, Cutrone E, Kotenko S, Krause C, Langer J: Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 1996, 21:1013-1015
28. Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K: siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res 2004, 32:W124-W129
29. Toyokuni S, Kawaguchi W, Akatsuka S, Hiroyasu M, Hiai H: Intermittent microwave irradiation facilitates antigen-antibody reaction in Western blot analysis. Pathol Int 2003, 53:259-261
30. Toyokuni S, Akatsuka S: What has been learned from the studies of oxidative stress-induced carcinogenesis: proposal of the concept of oxygenomics. J Clin Biochem Nutr 2006, 39:3-10
31. Toyokuni S, Akatsuka S: Pathological investigation of oxidative stress in the postgenomic era. Pathol Int 2007, 57:461-473
32. Okada S: Iran-induced tissue damage and cancer: the role of reactive oxygen free radicals. Pathol Int 1996, 46:311-332
33. Hunt C, Sim J, Sullivan S, Featherstone T, Golden W, Von Kapp-Herr C, Hock R, Gomez R, Persian A, Spitz D: Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress. Cancer Res 1998, 58:3986-3992
34. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
35. Albertson D: Gene amplification in cancer. Trends Genet 2006, 22:447-455
36. Cremer T, Cremer C: Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet 2001, 2:292-301
37. Meaburn KJ, Misteli T: Chromosome territories. Nature 2007, 445:379-381
38. Maranchie J, Vasselli J, Riss J, Bonifacino J, Linehan W, Klausner R: The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 2002, 1:247-255
39. Kondo K, Kico J, Nakamura E, Lechpammer M, Kaelin W: Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002, 1:237-246
40. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480
41. Chauhan A, Li Y, Deuel T: Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 1993, 90:679-682
42. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M, Deuel T: Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 2000, 97:2603-2608
43. Foehr E, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R: Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 2006, 66:2271-2278
44. Ulbricht U, Eckerich C, Fillbrandt R, Westphal M, Lamszus K: RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. J Neurochem 2006, 98:1497-1506
45. Harroch S, Furtado G, Brueck W, Rosenbluth J, Lafaille J, Chao M, Buxbaum J, Schlessinger J: A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat Genet 2002, 32:411-414
46. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T, Fukamachi H, Noda M: Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 2003, 33:375-381
47. Wang V, Davis D, Haque M, Huang L, Yarchoan R: Differential gene up-regulation by hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in HEK293T cells. Cancer Res 2005, 65:3299-3306
48. Nodwell A, Carmichael L, Ross M, Richardson B: Placental compared with umbilical cord blood to assess fetal blood gas and acid-base status. Obstet Gynecol 2005, 105:129-138
49. 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 2006, 11:286-296
50. Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S, Yoshida T, Nakamura H, Yodoi J: Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J 2005, 147:733-743
51. Chung C, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy B, Netterville J, Burkey B, Sinard R, Cmelak A, Levy S, Yarbrough W, Slebos R, Hirsch F: Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 2006, 24:4170-4176
52. Cullen K, Newkirk K, Schumaker L, Aldosari N, Rone J, Haddad B: Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 2003, 63:8097-8102